Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

Unveiling The Potential Of Psychedelic Therapies
Leading experts highlight the transformative potential of the rapidly evolving field of psychedelic therapies and underscore the importance of rigorous clinical trials and regulatory compliance.
Taking A Statistics-Driven Approach To Clinical Trial Planning
Clinical trials are inherently complex, and even well-structured studies may struggle to achieve statistical significance due to challenges in study design, patient selection, and data variability.
How To Improve Patient ID And Retention In Chronic Disease Trials
Leveraging primary care for chronic disease studies can accelerate patient identification, access to underrepresented populations, and improve retention rates.
Cell And Gene Therapy Field Quiet In Q2
While there weren't any new gene or cell therapy approvals in Q2 2024, the U.S. approved two RNA therapies: Rytelo, an oligonucleotide telomerase inhibitor, and mRESVIA, an mRNA vaccine.

Podcast―Nonclinical Considerations When Developing Ophthalmic Drugs
2/20/2025

Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.
Analyzing The FDA's Approach To Diversity In Clinical Trials
1/31/2025

Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
RTSM And IRT Solutions For Clinical Trials
12/10/2025

Global leader in RTSM/IRT, helping sponsors and CROs speed study start-up, optimize supply, and manage complex trials with confidence.
How Community-Based Research Models Expand Access
9/9/2025

As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?
Everything You Need To Know About Mobile Visits And Community Sites
10/11/2024

Discover how decentralized clinical trials (DCTs) and mobile visits contribute to more diverse, efficient, and patient-centric research, ultimately enhancing trial outcomes and data quality.

Dynamic RTSM Featuring Configurable, Pre-Validated Components

Your trusted RTSM solution, PULSE is designed to support all study designs with configurable, pre-validated components. PULSE empowers study teams to easily manage randomization and trial supply workflows with flexibility and precision.
Introducing Citeline PatientMatch: Precision Patient Recruitment

The window for identifying the right patients to enroll in clinical trials is shrinking. With Citeline PatientMatch, sponsors can pinpoint eligible patients before a treatment plan is finalized.
Cardiovascular, Renal And Metabolic Clinical Development

CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.
Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios

Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.
Human Abuse Potential

With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.